A multicenter, randomized, partially blinded phase 1 clinical trial to evaluate the safety and serum concentrations of a human monoclonal antibody, VRC-HIVMAB075-00-AB (VRC07-523LS), administered in multiple doses and routes to healthy, HIV-uninfected adults.
*Authenticated users only (create your account here)
HVTN 127/HPTN 087 Version 2.0
- HVTN 127/HPTN 087 Protocol V2.0 - 8 March 2018
- HVTN 127/HPTN 087 Protocol V2.0, Clarification Memo #1 - 4 April 2018
HVTN 127/HPTN 087 Version 1.0